Skip to content
MedsAcross

Medicine

Tacrolimus 1 mg capsule

Tacrolimus · Oral
Available on requestPrescription onlyUS FDAGeneric name

Tacrolimus 1 mg capsule is a generic prescription medicine for oral use, made by 28 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store and Dispense Store at 20°C to 25°C (77°F), excursions permitted to 15°C…

Key facts

Active ingredient (INN)
Tacrolimus
Brand
Sold under the generic name
Strength
1 mg
Dosage form
Capsule
Route
Oral
Packs
100 capsules, 50 blister pack, 30 capsules and 38 more
Manufacturers
Dr. Reddy's LaboratoriesIndiaAscend LaboratoriesIndiaConcord BiotechIndiaGlenmark PharmaceuticalsIndiaStrides PharmaIndiaAccord HealthcareIndiaBioconIndiaJubilant Cadista PharmaceuticalsIndiaPanacea BiotecIndiaProficient Rx28 labelers on the register
Origin register
US FDA, United States
Storage
Store and Dispense Store at 20°C to 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
D11AH01 Tacrolimus
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
10 August 2009
Identifiers
RxCUI 198377, 198378, 313190 +3DailyMed set ID bd9fea26-0236-d437-c7df-4b7636210875, 3e8bc65e-8048-4073-8e45-570330603000, 55467f4b-8437-43a3-b6d9-1bc2a13b4c11 +28NDC 43817-422, 54288-135, 67877-279 +28Application ANDA090802, ANDA206651, ANDA203740 +8

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 28 labelers. The register lists 41 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
100 capsule in 1 bottle16729-042-01Accord HealthcareIndia30 September 2011
100 capsule in 1 bottle67877-279-01Ascend LaboratoriesIndia13 November 2020
50 blister pack in 1 carton / 1 capsule in 1 blister pack67877-279-33Ascend LaboratoriesIndia13 November 2020
100 capsule in 1 bottle70377-015-11BioconIndia23 December 2020
100 capsule in 1 bottle68254-5005-1Concord BiotechIndia23 November 2020
30 capsule in 1 bottle68254-5005-5Concord BiotechIndia23 November 2020
1 bottle in 1 carton / 100 capsule in 1 bottle55111-526-01Dr. Reddy's LaboratoriesIndia14 May 2010
1 bottle in 1 carton / 500 capsule in 1 bottle55111-526-05Dr. Reddy's LaboratoriesIndia14 May 2010
1 bottle in 1 carton / 30 capsule in 1 bottle55111-526-30Dr. Reddy's LaboratoriesIndia14 May 2010
10 blister pack in 1 carton / 10 capsule in 1 blister pack55111-526-78Dr. Reddy's LaboratoriesIndia14 May 2010
100 capsule in 1 bottle68462-686-01Glenmark PharmaceuticalsIndia10 November 2020
10 blister pack in 1 carton / 10 capsule in 1 blister pack68462-686-14Glenmark PharmaceuticalsIndia10 November 2020
100 capsule, gelatin coated in 1 bottle59746-799-01Jubilant Cadista PharmaceuticalsIndia30 November 2024
100 capsule, gelatin coated in 1 bottle43817-422-01Panacea BiotecIndia26 February 2016
10 blister pack in 1 carton / 10 capsule in 1 blister pack64380-721-01Strides PharmaIndia13 August 2014
100 capsule in 1 container64380-721-06Strides PharmaIndia13 August 2014
100 capsule in 1 bottle82983-401-10Ajenat Pharmaceuticals31 January 2023
100 capsule in 1 bottle54288-135-01BPI Labs8 April 2020
100 capsule in 1 bottle, plastic0378-2046-01Mylan Pharmaceuticals17 September 2010
100 blister pack in 1 carton / 1 capsule in 1 blister pack51079-818-20MylanInstitutional1 November 2010
100 capsule in 1 bottle0781-2103-01Sandoz10 August 2009
100 capsule in 1 bottle85972-102-01Stellon Biotech7 August 2025
30 capsule in 1 bottle85972-102-30Stellon Biotech7 August 2025
90 capsule in 1 bottle50090-5581-0A-S Medication Solutions6 July 2021
90 capsule in 1 bottle50090-5596-0A-S Medication Solutions23 July 2021
100 capsule in 1 bottle63629-8723-1Bryant Ranch Prepack5 September 2024
60 capsule in 1 bottle63629-9325-1Bryant Ranch Prepack11 July 2022
2000 capsule in 1 bottle55154-4080-8Cardinal Health23 December 2020
10 blister pack in 1 bag / 1 capsule in 1 blister pack55154-4168-0Cardinal Health13 August 2014
100 blister pack in 1 box, unit-dose / 1 capsule in 1 blister pack68084-450-01American Health Packaging3 August 2010
9000 capsule in 1 bottle, plastic43353-317-09Aphena Pharma Solutions - Tennessee3 May 2017
50 blister pack in 1 box / 1 capsule in 1 blister pack50268-737-15AvPAK20 September 2026
30 capsule in 1 bottle72189-536-30Direct_Rx7 February 2024
100 capsule in 1 bottle, plastic60429-378-01Golden State Medical Supply18 November 2015
100 blister pack in 1 carton / 1 capsule in 1 blister pack0904-7097-61Major Pharmaceuticals13 August 2014
100 capsule in 1 bottle16714-099-01Northstar RX31 March 2021
30 capsule in 1 bottle82804-032-30Proficient Rx25 October 2023
60 capsule in 1 bottle82804-032-60Proficient Rx25 October 2023
90 capsule in 1 bottle82804-032-90Proficient Rx25 October 2023
100 capsule in 1 bottle82009-054-01Quallent Pharmaceuticals Health20 July 2023

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 8 April 1994Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Tacrolimus 1 mg capsule.

Compare 1

Other strengths and forms of Tacrolimus

Clinical summary

Tacrolimus is a calcineurin inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in adult and pediatric patients receiving allogeneic liver, kidney, heart, or lung transplants, in combination with other immunosuppressants. MedsAcross supplies Tacrolimus for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Tacrolimus

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Tacrolimus 1 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.